{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:55:34Z","timestamp":1790888134385,"version":"4.1.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01383","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:25:45Z","timestamp":1594081545000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":100,"title":["Norovirus Vaccine: Priorities for Future Research and Development"],"prefix":"10.3389","volume":"11","author":[{"given":"Susanna","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Principi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"key":"B1","first-page":"615","article-title":"Norwalk agent-like particles associated with gastroenteritis in human beings","volume":"173","author":"Dolin","year":"1978","journal-title":"J Am Vet Med Assoc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3109\/00365548.2011.588610","article-title":"Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009\u20132010","volume":"43","author":"Puustinen","year":"2011","journal-title":"Scand J Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/med.21545","article-title":"Norovirus antivirals: where are we now?","volume":"39","author":"Netzler","year":"2019","journal-title":"Med Res Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"7315","DOI":"10.1016\/j.vaccine.2016.10.090","article-title":"WHO product development for vaccines advisory committee. report from the world health organization's third product development for vaccines advisory committee (PDVAC) meeting, Geneva, 8-10th June (2016)","volume":"37","author":"Giersing","year":"2019","journal-title":"Vaccine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/14760584.2018.1510327","article-title":"Progress on norovirus vaccine research: public health considerations and future directions","volume":"17","author":"Mattison","year":"2018","journal-title":"Expert Rev Vaccines."},{"key":"B6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study (2013)","volume":"386","year":"2015","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/1471-2458-12-220","article-title":"Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review","volume":"12","author":"Fischer Walker","year":"2012","journal-title":"BMC Public Health"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study (2010)","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1017\/S0950268812000799","article-title":"The estimated disease burden of norovirus in the Netherlands","volume":"141","author":"Verhoef","year":"2013","journal-title":"Epidemiol Infect."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/aje\/kwq021","article-title":"Community incidence of norovirus-associated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis","volume":"171","author":"Phillips","year":"2010","journal-title":"Am J Epidemiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/gut.2011.238386","article-title":"Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice","volume":"61","author":"Tam","year":"2012","journal-title":"Gut"},{"key":"B12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1089\/fpd.2012.1389","article-title":"Estimates of the burden of foodborne illness in Canada for 30 specified pathogens and unspecified agents, circa (2006)","volume":"10","author":"Thomas","year":"2013","journal-title":"Foodborne Pathog Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3201\/eid1708.101533","article-title":"Incidence of acute gastroenteritis and role of norovirus, Georgia, USA, 2004\u20132005","volume":"17","author":"Hall","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10096-009-0729-1","article-title":"Incidence and risk factors for community-acquired acute gastroenteritis in north-west Germany 2004","volume":"28","author":"Karsten","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1093\/infdis\/jiv411","article-title":"Age-specific incidence rates for norovirus in the community and presenting to primary healthcare facilities in the United Kingdom","volume":"213","author":"O'Brien","year":"2016","journal-title":"J Infect Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.ajic.2015.04.182","article-title":"Norovirus prevention and the prevalence of asymptomatic norovirus infection in kindergartens and primary schools in Changzhou, China: Status of the knowledge, attitudes, behaviors, and requirements","volume":"43","author":"Qi","year":"2015","journal-title":"Am J Infect Control."},{"key":"B17","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/jmv.10346","article-title":"Incidence and characteristics of endemic norwalk-like virus-associated gastroenteritis","volume":"69","author":"Marshall","year":"2003","journal-title":"J Med Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1001999","DOI":"10.1371\/journal.pmed.1001999","article-title":"The vast and varied global burden of norovirus: prospects for prevention and control","volume":"13","author":"Lopman","year":"2016","journal-title":"PLoS Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.idc.2017.07.012","article-title":"Norovirus infection in older adults: epidemiology, risk factors, and opportunities for prevention and control","volume":"31","author":"Cardemil","year":"2017","journal-title":"Infect Dis Clin North Am."},{"key":"B20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1188\/13.ONF.434-436","article-title":"Norovirus gastroenteritis in immunocompromised patients. Norovirus in immunocompromised patients","volume":"40","author":"Bok","year":"2013","journal-title":"Oncol Nurs Forum"},{"key":"B21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.antiviral.2014.02.012","article-title":"Treatment of norovirus infections: moving antivirals from the bench to the bedside","author":"Kaufman","year":"2014","journal-title":"Antiviral Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ajic.2012.08.002","article-title":"Clinical characteristics of norovirus-associated deaths: a systematic literature review","volume":"41","author":"Trivedi","year":"2013","journal-title":"Am J Infect Control"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0151219","DOI":"10.1371\/journal.pone.0151219","article-title":"Global economic burden of norovirus gastroenteritis","volume":"11","author":"Bartsch","year":"2016","journal-title":"PLoS ONE."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jmv.21237","article-title":"Norwalk virus: how infectious is it?","volume":"80","author":"Teunis","year":"2008","journal-title":"J Med Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/QCO.0000000000000557","article-title":"Norovirus in health care and implications for the immunocompromised host","volume":"32","author":"Chong","year":"2019","journal-title":"Curr Opin Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00705-013-1708-5","article-title":"Proposal for a unified norovirus nomenclature and genotyping","volume":"158","author":"Kroneman","year":"2013","journal-title":"Arch Virol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S1473-3099(18)30059-8","article-title":"Molecular surveillance of norovirus, 2005-16: an epidemiological analysis of data collected from the NoroNet network","volume":"18","author":"van Beek","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1006136","DOI":"10.1371\/journal.ppat.1006136","article-title":"Static and evolving norovirus genotypes: implications for epidemiology and immunity","volume":"13","author":"Parra","year":"2017","journal-title":"PLoS Pathog."},{"key":"B29","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1128\/JVI.00674-07","article-title":"Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to (2006)","volume":"81","author":"Siebenga","year":"2007","journal-title":"J Virol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1086\/605127","article-title":"Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007","volume":"200","author":"Siebenga","year":"2009","journal-title":"J Infect Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1128\/JCM.00455-17","article-title":"Genetic and epidemiologic trends of norovirus outbreaks in the united states from 2013 to (2016). Demonstrated emergence of novel GII.4 recombinant viruses","volume":"55","author":"Cannon","year":"2017","journal-title":"J Clin Microbiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/QCO.0000000000000476","article-title":"Human noroviruses: recent advances in a 50-year history","volume":"31","author":"Atmar","year":"2018","journal-title":"Curr Opin Infect Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1056\/NEJM197707142970204","article-title":"Clinical immunity in acute gastroenteritis caused by norwalk agent","volume":"297","author":"Parrino","year":"1977","journal-title":"N Engl J Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/INF.0b013e3181a4bb60","article-title":"Symptomatic and asymptomatic rotavirus and norovirus infections during infancy in a chilean birth cohort","volume":"28","author":"O'Ryan","year":"2009","journal-title":"Pediatr Infect Dis J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/infdis\/151.1.99","article-title":"Evidence of immunity induced by naturally acquired rotavirus and norwalk virus infection on two remote panamanian islands","volume":"151","author":"Ryder","year":"1985","journal-title":"J Infect Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/infdis\/161.1.18","article-title":"Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults","volume":"161","author":"Johnson","year":"1990","journal-title":"J Infect Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/v11030226","article-title":"Genetic susceptibility to human norovirus infection: an update","volume":"11","author":"Nordgren","year":"2019","journal-title":"Viruses."},{"key":"B38","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1128\/CVI.00196-15","article-title":"Serological correlates of protection against a GII.4 norovirus","volume":"22","author":"Atmar","year":"2015","journal-title":"Clin Vaccine Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/v10010027","article-title":"Development of a surrogate neutralization assay for norovirus vaccine evaluation at the cellular level","volume":"10","author":"Wang","year":"2018","journal-title":"Viruses."},{"key":"B40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/infdis\/jiv053","article-title":"Mucosal and cellular immune responses to norwalk virus","volume":"212","author":"Ramani","year":"2015","journal-title":"J Infect Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1586\/erv.12.145","article-title":"Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis","volume":"12","author":"Richardson","year":"2013","journal-title":"Expert Rev Vaccines."},{"key":"B42","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.1128\/JVI.66.11.6527-6532.1992","article-title":"Expression, self-assembly, and antigenicity of the norwalk virus capsid protein","volume":"66","author":"Jiang","year":"1992","journal-title":"J Virol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1128\/JVI.76.6.3023-3030.2002","article-title":"Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons","volume":"76","author":"Baric","year":"2002","journal-title":"J Virol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e63269","DOI":"10.1371\/journal.pone.0063269","article-title":"Norovirus P particle efficiently elicits innate, humoral and cellular immunity","volume":"8","author":"Fang","year":"2013","journal-title":"PLoS ONE."},{"key":"B45","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.vaccine.2007.11.039","article-title":"Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice","volume":"26","author":"Guo","year":"2008","journal-title":"Vaccine."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.clinthera.2017.07.002","article-title":"Prospects and challenges in the development of a norovirus vaccine","volume":"39","author":"Cortes-Penfield","year":"2017","journal-title":"Clin Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human norwalk virus illness","volume":"365","author":"Atmar","year":"2011","journal-title":"N Engl J Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.clim.2012.05.006","article-title":"Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers","volume":"144","author":"Ramirez","year":"2012","journal-title":"Clin Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0177310","DOI":"10.1371\/journal.pone.0177310","article-title":"Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder","volume":"12","author":"Ball","year":"2017","journal-title":"PLoS ONE."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1128\/JVI.02179-09","article-title":"Heterotypic humoral and cellular immune responses following norwalk virus infection","volume":"84","author":"Lindesmith","year":"2010","journal-title":"J Virol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1016\/j.vaccine.2012.03.050","article-title":"Immunogenicity and specificity of norovirus consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations","volume":"30","author":"Parra","year":"2012","journal-title":"Vaccine."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/infdis\/jiu337","article-title":"A novel intramuscular bivalent norovirus virus-like particle vaccine candidate\u2013reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults","volume":"210","author":"Treanor","year":"2014","journal-title":"J Infect Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.vaccine.2014.09.073","article-title":"Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine","volume":"33","author":"Sundararajan","year":"2015","journal-title":"Vaccine."},{"key":"B54","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/infdis\/jiu497","article-title":"Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults","volume":"211","author":"Bernstein","year":"2015","journal-title":"J Infect Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/infdis\/jiw259","article-title":"Rapid responses to 2 virus-like particle norovirus vaccine candidate formulations in healthy adults: a randomized controlled trial","volume":"214","author":"Atmar","year":"2016","journal-title":"J Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/infdis\/jix572","article-title":"Safety and immunogenicity of different formulations of norovirus vaccine candidate in healthy adults: a randomized, controlled, double-blind clinical trial","volume":"217","author":"Leroux-Roels","year":"2018","journal-title":"J Infect Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"S674","DOI":"10.1093\/ofid\/ofy210.1929","article-title":"Immunogenicity of takeda's bivalent virus-like particle (VLP) norovirus vaccine (NoV) candidate in children from 6 months up to 4 years of age","volume":"5","author":"Masuda","year":"2018","journal-title":"Open Forum Infect Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1016\/j.vaccine.2009.06.065","article-title":"A recombinant adenovirus prime-virus-like particle boost regimen elicits effective and specific immunities against norovirus in mice","volume":"27","author":"Guo","year":"2009","journal-title":"Vaccine."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e121077","DOI":"10.1172\/jci.insight.121077","article-title":"Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial","volume":"3","author":"Kim","year":"2018","journal-title":"JCI Insight."},{"key":"B60","unstructured":"Press Release DetailsVaxart Doses First Patient in Randomized Cohort of Bivalent Norovirus Vaccine Phase 1b Clinical Trial"},{"key":"B61","doi-asserted-by":"publisher","first-page":"8126","DOI":"10.1016\/j.vaccine.2011.08.026","article-title":"Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis","volume":"29","author":"Blazevic","year":"2011","journal-title":"Vaccine"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00705-015-2461-8","article-title":"Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine","volume":"160","author":"Lappalainen","year":"2015","journal-title":"Arch Virol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"9171632","DOI":"10.1155\/2016\/9171632","article-title":"Recombinant VP6 nanotubes act as an immunomodulator and delivery vehicle for norovirus virus-like particles","volume":"2016","author":"Malm","year":"2016","journal-title":"J Immunol Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e70409","DOI":"10.1371\/journal.pone.0070409","article-title":"Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice","volume":"8","author":"Tamminen","year":"2013","journal-title":"PLoS ONE."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.3390\/pharmaceutics11050229","article-title":"Rotavirus VP6 as an adjuvant for bivalent norovirus vaccine produced in nicotiana benthamiana","volume":"11","author":"Malm","year":"2019","journal-title":"Pharmaceutics."},{"key":"B66","doi-asserted-by":"publisher","first-page":"9728","DOI":"10.1128\/JVI.01249-14","article-title":"Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs","volume":"88","author":"Kocher","year":"2014","journal-title":"J Virol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.virol.2008.08.047","article-title":"Noroviral P particle: structure, function and applications in virus-host interaction","volume":"382","author":"Tan","year":"2008","journal-title":"Virology."},{"key":"B68","doi-asserted-by":"publisher","first-page":"7670","DOI":"10.1016\/j.vaccine.2011.07.139","article-title":"A candidate dual vaccine against influenza and noroviruses","volume":"29","author":"Xia","year":"2011","journal-title":"Vaccine."},{"key":"B69","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.1016\/j.vaccine.2015.09.043","article-title":"A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice","volume":"33","author":"Wang","year":"2015","journal-title":"Vaccine."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01383\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:25:52Z","timestamp":1594081552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01383\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2020.01383"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01383","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,7]]},"article-number":"1383"}}